Dark | Light
# Liquidia Corporation Common Stock (LQDA)

Liquidia's Yutrepia shows superior efficacy in patient trials, driving positive sentiment amidst ongoing patent litigation with United Therapeutics. Analysts predict a favorable ruling for Liquidia in the [---] patent case, potentially boosting the stock.

### About Liquidia Corporation Common Stock
Liquidia Corporation Common Stock (LQDA) is a biopharmaceutical company focused on developing treatments for pulmonary hypertension.  
Liquidia Corporation Common Stock uses the ticker $LQDA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Liquidia Corporation Common Stock (LQDA) social dominance is up 163.29% from the previous week.
- Liquidia Corporation Common Stock (LQDA) sentiment is up 49.25% from the previous week.

### Price: $38.20
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/close.tsv)  
The stock price has seen a surge to a 52-week and all-time high, driven by positive sales data, clinical trial results, and analyst upgrades, despite a recent 24-hour dip. Social media attention and positive sentiment surrounding clinical trial data and legal battles appear to be significant drivers.  

24-Hour: -2.15%
7-Day: -11.22%
30-Day: 0.71%

1-Year High: $46.60 on 2026-02-03  
1-Year Low: $12 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/alt_rank.tsv)  
Liquidia Corporation Common Stock (LQDA) is currently AltRank #310 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +168  
[--] Month: [---] +377  
[--] Months: [---] +479  
[--] Year: [---] +30  
1-Year High: [-----] on 2026-02-13  
1-Year Low: [--] on 2026-01-18  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +3  
[--] Month: [--] +20  
1-Year High: [--] on 2025-12-22  
1-Year Low: [--] on 2026-01-28  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] -21%  
[--] Month: [-------] -15%  
[--] Months: [---------] +20%  
[--] Year: [---------] -2.40%  
1-Year High: [-------] on 2025-08-08  
1-Year Low: [---] on 2025-03-16  

Engagements by network (24h):
X: [------]
News: [--]
YouTube: [--]
TikTok: [--]
Reddit: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -36%  
[--] Month: [-----] -6.60%  
[--] Months: [-----] +106%  
[--] Year: [-----] +269%  
1-Year High: [---] on 2026-01-21  
1-Year Low: [--] on 2025-04-07  

Mentions by network (24h):
X: [---]
News: [--]
YouTube: [--]
TikTok: [--]
Reddit: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Liquidia Corporation Common Stock (LQDA) in the last [--] hours which is down 7.90% from [---] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -36%  
[--] Month: [---] -4.40%  
[--] Months: [-----] +3.70%  
[--] Year: [-----] +166%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-04-07  

The most influential creators that mention Liquidia Corporation Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]     | [------]      |
| [@bglangner](/creator/twitter/bglangner)             | [--]    | [---]       | [--]     | [-----]       |
| [@AnnaFlorcia](/creator/twitter/AnnaFlorcia)         | [--]    | [-----]     | [--]     | [-----]       |
| [@scroogecapital](/creator/twitter/scroogecapital)   | [--]    | [-----]     | [--]     | [-----]       |
| [@AlphaHunte79332](/creator/twitter/AlphaHunte79332) | [--]    | [---]       | [--]     | [-----]       |
| [@from1to3000000](/creator/twitter/from1to3000000)   | [--]    | [-----]     | [--]     | [---]         |
| [@TcheeseRa](/creator/twitter/TcheeseRa)             | [--]    | [---]       | [--]     | [---]         |
| [@paperhands91](/creator/twitter/paperhands91)       | [--]    | [---]       | [--]     | [---]         |
| [@benittaaro](/creator/twitter/benittaaro)           | [--]    | [--]        | [--]     | [---]         |
| [@MrCryptoEurope](/creator/twitter/MrCryptoEurope)   | [--]   | [--]        | [--]     | [---]         |

[View More](/list/creators/$lqda/100)
  
  
### Sentiment: 86%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/sentiment.tsv)  
Current Value: 86%  
Daily Average: 78%  
[--] Week: 100% +33%  
[--] Month: 83% +12%  
[--] Months: 83% -8%  
[--] Year: 83% -12%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 36% on 2025-12-16  

Most Supportive Themes:
- Positive Clinical Trial Data and Efficacy: (30%) Posts highlight positive clinical trial data for Yutrepia (treprostinil inhalation powder) and L606, emphasizing superior efficacy and tolerability compared to competitors like United Therapeutics' Tyvaso.
- Upcoming Earnings and Financial Performance: (25%) Multiple posts mention upcoming earnings reports for LQDA, indicating anticipation for financial results. Positive financial performance and meeting or exceeding analyst expectations are seen as key drivers for stock price appreciation.
- Patent Litigation and Legal Battles: (20%) The ongoing patent disputes between Liquidia (LQDA) and United Therapeutics (UTHR) are a recurring theme. Positive outcomes in these legal battles, such as the denial of preliminary injunctions, are viewed as supportive of LQDA's market entry and growth.
  
Most Critical Themes:
- Legal Overhang and Uncertainty: (40%) Despite positive data, the persistent legal overhang from patent litigation with United Therapeutics (UTHR) creates significant uncertainty. The market's reaction to these legal battles, including potential injunctions, remains a critical factor influencing LQDA's stock price.
- Competition and Market Share: (35%) While LQDA's Yutrepia is seen as a superior product, competition from established players like UTHR remains a concern. The ability of LQDA to capture market share and displace competitors is a critical aspect of its long-term success.
  
  
  
### Social Dominance: 0.01%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/social_dominance.tsv)  
Current Value: 0.01%  
Daily Average: 0.018%  
[--] Week: 0.021% +0.013%  
[--] Month: 0.017% -0.014%  
[--] Months: 0.017% -0.012%  
[--] Year: 0.017% +0.0063%  
1-Year High: 0.07% on 2026-01-21  
1-Year Low: 0.0027% on 2025-04-07  
  
  
### Market Dominance: 0.00376%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/market_dominance.tsv)  
Current Value: 0.00376%  
Daily Average: 0%  
1-Year High: 0.173% on 2026-02-06  
1-Year Low: 0.00376% on 2026-02-13  
  
  
### Market Cap: $3,323,227,451
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$lqda/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$lqda/time-series/market_cap.tsv)  
Current Value: $3,323,227,451  
Daily Average: $3,199,548,872  
[--] Week: $3,323,227,451 -11%  
[--] Month: $3,323,227,451 -1.50%  
1-Year High: $4,056,599,372 on 2026-02-03  
1-Year Low: $2,672,501,238 on 2026-01-06  

### Top Liquidia Corporation Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@biotech_hunter I sold before the dip at $53 and never bought back. Rotated into more $abvx and $lqda so I'm missing out on the $nktr gains.but I'm still happy for the nektards"  
[X Link](https://x.com/bioadvo/status/2022545569227427938) [@bioadvo](/creator/x/bioadvo) 2026-02-14T05:36Z [---] followers, [---] engagements


"Most Rwa projects tokenize exposure. Bdtc tokenizes ownership $nvda $tsla $sofi $doge $bnb $meta $nvo $xpl $lqda $dash $sol #ethereum $open $aster #liquidity $cifr $iren $wild $mon $btc $oscr #bitcoin 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital currency to real redeemable gold. 🟡 Gold-backed design linking digital units to audited reserves 🟡 Decentralized issuance without institutional control 🟡 On-chain https://t.co/9qxf18uUos 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital"  
[X Link](https://x.com/anyuser/status/2022453085008990519) [@undefined](/creator/x/undefined) 2026-02-13T23:29Z [--] followers, [---] engagements


"Collateral that exists outside the screen changes the risk profile completely $lqda $xpl $nvo $meta $bnb $doge $nvda $tsla $sofi #liquidity $cifr $iren #ethereum $open $aster $sol $dash $pltr $wild $mon $btc $oscr #bitcoin 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital currency to real redeemable gold. 🟡 Gold-backed design linking digital units to audited reserves 🟡 Decentralized issuance without institutional control 🟡 On-chain https://t.co/9qxf18uUos 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC"  
[X Link](https://x.com/benittaaro/status/2022442489177948279) [@benittaaro](/creator/x/benittaaro) 2026-02-13T22:47Z [--] followers, [---] engagements


"Anchoring supply to gold forces monetary responsibility #ethereum $open $aster $sol $dash $pltr #liquidity $cifr $iren $wild $mon $btc #bitcoin $oscr $lqda $xpl $nvo $meta $bnb $doge $nvda $tsla $sofi 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital currency to real redeemable gold. 🟡 Gold-backed design linking digital units to audited reserves 🟡 Decentralized issuance without institutional control 🟡 On-chain https://t.co/9qxf18uUos 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital"  
[X Link](https://x.com/jackhaulee/status/2022438809007177882) [@jackhaulee](/creator/x/jackhaulee) 2026-02-13T22:32Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Liquidia Corporation Common Stock (LQDA)

Liquidia's Yutrepia shows superior efficacy in patient trials, driving positive sentiment amidst ongoing patent litigation with United Therapeutics. Analysts predict a favorable ruling for Liquidia in the [---] patent case, potentially boosting the stock.

About Liquidia Corporation Common Stock

Liquidia Corporation Common Stock (LQDA) is a biopharmaceutical company focused on developing treatments for pulmonary hypertension.
Liquidia Corporation Common Stock uses the ticker $LQDA for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Liquidia Corporation Common Stock (LQDA) social dominance is up 163.29% from the previous week.
  • Liquidia Corporation Common Stock (LQDA) sentiment is up 49.25% from the previous week.

Price: $38.20

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has seen a surge to a 52-week and all-time high, driven by positive sales data, clinical trial results, and analyst upgrades, despite a recent 24-hour dip. Social media attention and positive sentiment surrounding clinical trial data and legal battles appear to be significant drivers.

24-Hour: -2.15% 7-Day: -11.22% 30-Day: 0.71%

1-Year High: $46.60 on 2026-02-03
1-Year Low: $12 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Liquidia Corporation Common Stock (LQDA) is currently AltRank #310 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] +168
[--] Month: [---] +377
[--] Months: [---] +479
[--] Year: [---] +30
1-Year High: [-----] on 2026-02-13
1-Year Low: [--] on 2026-01-18

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +3
[--] Month: [--] +20
1-Year High: [--] on 2025-12-22
1-Year Low: [--] on 2026-01-28

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] -21%
[--] Month: [-------] -15%
[--] Months: [---------] +20%
[--] Year: [---------] -2.40%
1-Year High: [-------] on 2025-08-08
1-Year Low: [---] on 2025-03-16

Engagements by network (24h): X: [------] News: [--] YouTube: [--] TikTok: [--] Reddit: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -36%
[--] Month: [-----] -6.60%
[--] Months: [-----] +106%
[--] Year: [-----] +269%
1-Year High: [---] on 2026-01-21
1-Year Low: [--] on 2025-04-07

Mentions by network (24h): X: [---] News: [--] YouTube: [--] TikTok: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Liquidia Corporation Common Stock (LQDA) in the last [--] hours which is down 7.90% from [---] in the previous [--] hours Daily Average: [--]
[--] Week: [---] -36%
[--] Month: [---] -4.40%
[--] Months: [-----] +3.70%
[--] Year: [-----] +166%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-04-07

The most influential creators that mention Liquidia Corporation Common Stock in the last [--] hours

Creator Rank Followers Posts Engagements
@seedy19tron [--] [------] [--] [------]
@bglangner [--] [---] [--] [-----]
@AnnaFlorcia [--] [-----] [--] [-----]
@scroogecapital [--] [-----] [--] [-----]
@AlphaHunte79332 [--] [---] [--] [-----]
@from1to3000000 [--] [-----] [--] [---]
@TcheeseRa [--] [---] [--] [---]
@paperhands91 [--] [---] [--] [---]
@benittaaro [--] [--] [--] [---]
@MrCryptoEurope [--] [--] [--] [---]

View More

Sentiment: 86%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 86%
Daily Average: 78%
[--] Week: 100% +33%
[--] Month: 83% +12%
[--] Months: 83% -8%
[--] Year: 83% -12%
1-Year High: 100% on 2025-02-15
1-Year Low: 36% on 2025-12-16

Most Supportive Themes:

  • Positive Clinical Trial Data and Efficacy: (30%) Posts highlight positive clinical trial data for Yutrepia (treprostinil inhalation powder) and L606, emphasizing superior efficacy and tolerability compared to competitors like United Therapeutics' Tyvaso.
  • Upcoming Earnings and Financial Performance: (25%) Multiple posts mention upcoming earnings reports for LQDA, indicating anticipation for financial results. Positive financial performance and meeting or exceeding analyst expectations are seen as key drivers for stock price appreciation.
  • Patent Litigation and Legal Battles: (20%) The ongoing patent disputes between Liquidia (LQDA) and United Therapeutics (UTHR) are a recurring theme. Positive outcomes in these legal battles, such as the denial of preliminary injunctions, are viewed as supportive of LQDA's market entry and growth.

Most Critical Themes:

  • Legal Overhang and Uncertainty: (40%) Despite positive data, the persistent legal overhang from patent litigation with United Therapeutics (UTHR) creates significant uncertainty. The market's reaction to these legal battles, including potential injunctions, remains a critical factor influencing LQDA's stock price.
  • Competition and Market Share: (35%) While LQDA's Yutrepia is seen as a superior product, competition from established players like UTHR remains a concern. The ability of LQDA to capture market share and displace competitors is a critical aspect of its long-term success.

Social Dominance: 0.01%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.01%
Daily Average: 0.018%
[--] Week: 0.021% +0.013%
[--] Month: 0.017% -0.014%
[--] Months: 0.017% -0.012%
[--] Year: 0.017% +0.0063%
1-Year High: 0.07% on 2026-01-21
1-Year Low: 0.0027% on 2025-04-07

Market Dominance: 0.00376%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00376%
Daily Average: 0%
1-Year High: 0.173% on 2026-02-06
1-Year Low: 0.00376% on 2026-02-13

Market Cap: $3,323,227,451

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,323,227,451
Daily Average: $3,199,548,872
[--] Week: $3,323,227,451 -11%
[--] Month: $3,323,227,451 -1.50%
1-Year High: $4,056,599,372 on 2026-02-03
1-Year Low: $2,672,501,238 on 2026-01-06

Top Liquidia Corporation Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"@biotech_hunter I sold before the dip at $53 and never bought back. Rotated into more $abvx and $lqda so I'm missing out on the $nktr gains.but I'm still happy for the nektards"
X Link @bioadvo 2026-02-14T05:36Z [---] followers, [---] engagements

"Most Rwa projects tokenize exposure. Bdtc tokenizes ownership $nvda $tsla $sofi $doge $bnb $meta $nvo $xpl $lqda $dash $sol #ethereum $open $aster #liquidity $cifr $iren $wild $mon $btc $oscr #bitcoin 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital currency to real redeemable gold. 🟡 Gold-backed design linking digital units to audited reserves 🟡 Decentralized issuance without institutional control 🟡 On-chain https://t.co/9qxf18uUos 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital"
X Link @undefined 2026-02-13T23:29Z [--] followers, [---] engagements

"Collateral that exists outside the screen changes the risk profile completely $lqda $xpl $nvo $meta $bnb $doge $nvda $tsla $sofi #liquidity $cifr $iren #ethereum $open $aster $sol $dash $pltr $wild $mon $btc $oscr #bitcoin 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital currency to real redeemable gold. 🟡 Gold-backed design linking digital units to audited reserves 🟡 Decentralized issuance without institutional control 🟡 On-chain https://t.co/9qxf18uUos 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC"
X Link @benittaaro 2026-02-13T22:47Z [--] followers, [---] engagements

"Anchoring supply to gold forces monetary responsibility #ethereum $open $aster $sol $dash $pltr #liquidity $cifr $iren $wild $mon $btc #bitcoin $oscr $lqda $xpl $nvo $meta $bnb $doge $nvda $tsla $sofi 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital currency to real redeemable gold. 🟡 Gold-backed design linking digital units to audited reserves 🟡 Decentralized issuance without institutional control 🟡 On-chain https://t.co/9qxf18uUos 🪙 $BDTC: GOLD AS THE FOUNDATION Digital currency evolved. Trust lagged behind. BDTC anchors digital"
X Link @jackhaulee 2026-02-13T22:32Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Liquidia Corporation Common Stock (LQDA)
/topic/$lqda